These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 2822825

  • 1. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
    Sibille Y, Naegel GP, Merrill WW, Young KR, Care SB, Reynolds HY.
    J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
    [Abstract] [Full Text] [Related]

  • 2. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
    Kazmierowski JA, Gallin JI, Reynolds HY.
    J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
    [Abstract] [Full Text] [Related]

  • 3. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
    Desai U, Dickey B, Varani J, Kreutzer DL.
    J Exp Pathol; 1984 Feb; 1(3):201-16. PubMed ID: 6400640
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA, Justice JM, Rasmussen JK, Russ WD, Thomas KR, Rennard SI.
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients.
    Teran LM, Campos MG, Begishvilli BT, Schröder JM, Djukanovic R, Shute JK, Church MK, Holgate ST, Davies DE.
    Clin Exp Allergy; 1997 Apr; 27(4):396-405. PubMed ID: 9146932
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
    Martin TR, Raugi G, Merritt TL, Henderson WR.
    J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
    [Abstract] [Full Text] [Related]

  • 10. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF, Yuen C, Perez HD, Goldstein IM.
    J Immunol; 1986 May 01; 136(9):3412-9. PubMed ID: 3514759
    [Abstract] [Full Text] [Related]

  • 11. Macrophage inflammatory protein-1 alpha expression in interstitial lung disease.
    Standiford TJ, Rolfe MW, Kunkel SL, Lynch JP, Burdick MD, Gilbert AR, Orringer MB, Whyte RI, Strieter RM.
    J Immunol; 1993 Sep 01; 151(5):2852-63. PubMed ID: 8360496
    [Abstract] [Full Text] [Related]

  • 12. Neutrophil chemotactic factors in bacterial pneumonia.
    Hopkins H, Stull T, Von Essen SG, Robbins RA, Rennard SI.
    Chest; 1989 May 01; 95(5):1021-7. PubMed ID: 2539955
    [Abstract] [Full Text] [Related]

  • 13. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M, Constantin MC, Nicolau A, Hirt M, Galatiuc C, Matei I, Braşoveanu LI, Iordăchescu D.
    Roum Arch Microbiol Immunol; 2002 May 01; 61(4):243-58. PubMed ID: 15055258
    [Abstract] [Full Text] [Related]

  • 14. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
    Rosenbaum JT, Wong K, Perez HD, Raymond W, Howes EL.
    Invest Ophthalmol Vis Sci; 1984 Oct 01; 25(10):1184-91. PubMed ID: 6384121
    [Abstract] [Full Text] [Related]

  • 15. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.
    Ozaki T, Hayashi H, Tani K, Ogushi F, Yasuoka S, Ogura T.
    Am Rev Respir Dis; 1992 Jan 01; 145(1):85-91. PubMed ID: 1309969
    [Abstract] [Full Text] [Related]

  • 16. Human alveolar macrophages from smokers have an impaired capacity to secrete LTB4 but not other chemotactic factors.
    Wieslander E, Linden M, Håkansson L, Eklund A, Blaschke E, Brattsand R, Venge P.
    Eur J Respir Dis; 1987 Oct 01; 71(4):263-72. PubMed ID: 2826202
    [Abstract] [Full Text] [Related]

  • 17. Human alveolar macrophages release a factor that inhibits phagocyte function.
    Sibille Y, Merrill WW, Naegel GP, Care SB, Cooper JA, Reynolds HY.
    Am J Respir Cell Mol Biol; 1989 Nov 01; 1(5):407-16. PubMed ID: 2561589
    [Abstract] [Full Text] [Related]

  • 18. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.
    Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J, Crystal RG.
    J Clin Invest; 1991 Sep 01; 88(3):891-7. PubMed ID: 1653278
    [Abstract] [Full Text] [Related]

  • 19. Changes in the broncho-alveolar lavage fluid in smokers and patients with chronic obstructive lung disease.
    Terpstra GK, Wassink GA, Huidekoper HJ.
    Int J Clin Pharmacol Res; 1987 Sep 01; 7(5):357-61. PubMed ID: 3312045
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of inflammatory cytokine secretion by human alveolar macrophages.
    Losa García JE, Rodríguez FM, Martín de Cabo MR, García Salgado MJ, Losada JP, Villarón LG, López AJ, Arellano JL.
    Mediators Inflamm; 1999 Sep 01; 8(1):43-51. PubMed ID: 10704089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.